These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951 [TBL] [Abstract][Full Text] [Related]
3. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus. Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203 [TBL] [Abstract][Full Text] [Related]
4. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694 [TBL] [Abstract][Full Text] [Related]
5. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. McCullough KC; Crowther JR; Butcher RN; Carpenter WC; Brocchi E; Capucci L; De Simone F Immunology; 1986 Jul; 58(3):421-8. PubMed ID: 3015780 [TBL] [Abstract][Full Text] [Related]
6. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules. Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933 [TBL] [Abstract][Full Text] [Related]
7. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif. Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785 [TBL] [Abstract][Full Text] [Related]
8. Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants. Butchaiah G; Morgan DO Virus Res; 1997 Dec; 52(2):183-94. PubMed ID: 9495534 [TBL] [Abstract][Full Text] [Related]
9. Antibody and host cell recognition of foot-and-mouth disease virus (serotype C) cleaved at the Arg-Gly-Asp (RGD) motif: a structural interpretation. Hernández J; Valero ML; Andreu D; Domingo E; Mateu MG J Gen Virol; 1996 Feb; 77 ( Pt 2 )():257-64. PubMed ID: 8627229 [TBL] [Abstract][Full Text] [Related]
10. Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. Verdaguer N; Mateu MG; Andreu D; Giralt E; Domingo E; Fita I EMBO J; 1995 Apr; 14(8):1690-6. PubMed ID: 7537661 [TBL] [Abstract][Full Text] [Related]
11. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. Verdaguer N; Sevilla N; Valero ML; Stuart D; Brocchi E; Andreu D; Giralt E; Domingo E; Mateu MG; Fita I J Virol; 1998 Jan; 72(1):739-48. PubMed ID: 9420281 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367 [TBL] [Abstract][Full Text] [Related]
13. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies. Stave JW; Card JL; Morgan DO J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926 [TBL] [Abstract][Full Text] [Related]
14. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Stave JW; Card JL; Morgan DO; Vakharia VN Virology; 1988 Jan; 162(1):21-9. PubMed ID: 2827379 [TBL] [Abstract][Full Text] [Related]
15. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Saiz JC; Gonzalez MJ; Morgan DO; Card JL; Sobrino F; Moore DM Virus Res; 1989 May; 13(1):45-60. PubMed ID: 2473578 [TBL] [Abstract][Full Text] [Related]
16. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity? Yoden S; Kida H; Yanagawa R Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245 [TBL] [Abstract][Full Text] [Related]
17. Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Carrillo C; Plana J; Mascarella R; Bergadá J; Sobrino F Virology; 1990 Dec; 179(2):890-2. PubMed ID: 1700543 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus. Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972 [TBL] [Abstract][Full Text] [Related]
20. Antigenic relationships of foot-and-mouth disease virus serotype Asia-1 isolates demonstrated by monoclonal antibodies. Butchaiah G; Card JL; Morgan DO Vet Immunol Immunopathol; 1992 Jan; 30(2-3):275-92. PubMed ID: 1375792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]